NMPA Approval

Insulin Glulisine Injection

Approval Number

国药准字SJ20150008

Registration Date

March 5, 2024

Previous Approval Numbers

S20150008

Drug Information

Generic Name

谷赖胰岛素注射液

Trade Name

艾倍得

Dosage Form

注射剂

Strength

10ml:1000U/瓶

Drug Type

生物制品

Registration Date

March 5, 2024

Expiry Date

March 4, 2029

Company Address

Industriepark Hoechst, Brueningstrasse 50, D-65926 Frankfurt am Main, Germany

Company Address

Industriepark Hoechst, Brueningstrasse 50, D-65926 Frankfurt am Main, Germany

Empowering clinical research with data-driven insights and AI-powered tools.

谷赖胰岛素注射液 - NMPA 批准文号 | MedPath